ClinicalTrials.gov
public full text
Public Domain
Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms
Memantine as an add-on therapy to clozapine may improve schizophrenia negative symptoms and cognitive functioning.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls#883366
- Neurophysiological evaluation of sensory gating and selective attention in schizotypal personality#1020276
- Closed-loop TMS for the Core Clinical Features of the Methamphetamine Use Disorder#883754
- Phenome-Wide Association Study of <i>P2RX7</i> Identifies Schizophrenia and Mood Disorders as Primary Associated Phenotypes#277877
- Novel Adaptive Cognitive Training in Autistic Adults With Co-occurring Insomnia#1031156
Record · ID 835875
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive